Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis

Ziv Neeman, Steven K. Libutti, Jay W. Patti, Bradford J. Wood

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9×2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.

Original languageEnglish (US)
Pages (from-to)417-420
Number of pages4
JournalClinical Imaging
Volume27
Issue number6
DOIs
StatePublished - Jan 1 2003

Keywords

  • Hepatocellular carcinoma (HCC)
  • Portal vein thrombosis (PVT)
  • Radiofrequency ablation (RFA)

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis'. Together they form a unique fingerprint.

  • Cite this